COMETRIQ for Medullary thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where COMETRIQ was used for Medullary thyroid cancer.
Most Reported Side Effects for COMETRIQ
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 75 | 49.7% | 19 | 11 |
| Fatigue | 48 | 31.8% | 8 | 9 |
| Diarrhoea | 39 | 25.8% | 10 | 7 |
| Stomatitis | 29 | 19.2% | 2 | 6 |
| Nausea | 23 | 15.2% | 2 | 6 |
| Death | 20 | 13.3% | 20 | 7 |
| Decreased appetite | 18 | 11.9% | 6 | 4 |
| Dry mouth | 16 | 10.6% | 0 | 1 |
| Malignant neoplasm progression | 16 | 10.6% | 13 | 3 |
| Pain in extremity | 16 | 10.6% | 1 | 1 |
| Dysgeusia | 15 | 9.9% | 0 | 2 |
| Dysphonia | 15 | 9.9% | 3 | 2 |
| Asthenia | 14 | 9.3% | 3 | 7 |
| Dyspnoea | 13 | 8.6% | 4 | 3 |
| Hair colour changes | 10 | 6.6% | 0 | 1 |
Other Indications for COMETRIQ
Other Drugs Used for Medullary thyroid cancer
VANDETANIB (221)
CABOZANTINIB S-MALATE (165)
SELPERCATINIB (116)
CABOZANTINIB (73)
PRALSETINIB (48)
LENVATINIB (34)
SORAFENIB (18)
CAPRELSA (14)
OCTREOTIDE (14)
TARLATAMAB-DLLE (13)